Associated Papers
Exome sequencing identified compound heterozygous mutations in the SRD5A2 gene in a case of 46,XY ambiguous genitalia.
Mehta P et al.
Andrologia, 2021
Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.
Li J et al.
American Journal of Epidemiology, 2010
Androgen metabolic genes in prostate cancer predisposition and progression.
Makridakis NM et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2005
Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N et al.
Journal of Molecular Endocrinology, 2005
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
Makridakis NM et al.
Pharmacogenetics, 2000
Select a paper to view details